Last updated on September 2018

Study of Multiple Doses of PRS-060 Administered by Oral Inhalation in Subjects With Mild Asthma


Brief description of study

Study of Multiple Doses of PRS-060 Administered by Oral Inhalation in Subjects with Mild Asthma

Detailed Study Description

PRS-060 is a drug candidate being developed for the treatment of asthma. The main purpose of this study is to investigate the safety, tolerability, and pharmacokinetics of multiple doses of PRS-060 administered by inhalation in subjects with mild asthma.

Clinical Study Identifier: NCT03574805

Contact Investigators or Research Sites near you

Start Over

Thomas Polasek, MD

CMAX
Adelaide, Australia
  Connect »

Oscar Walsh, MD

Nucleus Network Limited
Melbourne, Australia
  Connect »